CART

(0) items

The Social Worker and Psychotropic Medication Toward Effective Collaboration with Mental Health Clients, Families, and Providers,9780534515515
This item qualifies for
FREE SHIPPING!
FREE SHIPPING OVER $59!

Your order must be $59 or more, you must select US Postal Service Shipping as your shipping preference, and the "Group my items into as few shipments as possible" option when you place your order.

Bulk sales, PO's, Marketplace Items, eBooks, Apparel, and DVDs not included.

The Social Worker and Psychotropic Medication Toward Effective Collaboration with Mental Health Clients, Families, and Providers

by ;
Edition:
3rd
ISBN13:

9780534515515

ISBN10:
0534515517
Format:
Paperback
Pub. Date:
7/26/2005
Publisher(s):
Brooks Cole

Questions About This Book?

What version or edition is this?
This is the 3rd edition with a publication date of 7/26/2005.
What is included with this book?
  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any CDs, lab manuals, study guides, etc.
  • The Used copy of this book is not guaranteed to include any supplemental materials. Typically, only the book itself is included.

Related Products


  • The Social Worker & Psychotropic Medication: Toward Effective Collaboration With Mental Health Clients, Families, and Providers
    The Social Worker & Psychotropic Medication: Toward Effective Collaboration With Mental Health Clients, Families, and Providers
  • The Social Worker and Psychotropic Medication Toward Effective Collaboration with Clients, Families, and Providers
    The Social Worker and Psychotropic Medication Toward Effective Collaboration with Clients, Families, and Providers





Summary

Presenting material within a contemporary framework of "partnership" practice that is rich with case examples, this up-to-date primer on psychopharmacology and psychosocial interventions serves as a useful resource for social work students and practitioners as they expand their daily roles in psychiatric medication management. Bentley and Walsh present all the facts, myths, and relevant information about psychotropic medication in an easy-to-access manner. Content on a variety of topics, including expanded coverage of children and adolescents, helps readers become more responsive to the medication-related concerns of mental health clients and work more collaboratively on these issues with families and other mental health care providers. Data from the authors' national survey of randomly selected NASW members provides readers with the information they need to be aware, articulate, and active with respect to clients' medication-related dilemmas, but also mindful of the sociopolitical context of prescription practice in psychiatry.

Table of Contents

List of Tables xiii
Preface xv
About the Authors xvii
PART I SOCIAL WORK ROLES IN MEDICATION MANAGEMENT 1(46)
1 History and Overview of Social Work Roles in Medication Management
3(24)
Four Case Scenarios: Introduction to Social Workers' Roles
3(4)
The Changing Roles of Social Workers
7(3)
Historical Context of Intervention for People with Mental Illness
10(3)
Treatment of People with Mental Illness Before 1950
10(1)
The Rise of Psychiatric Social Work
11(1)
The Introduction of Psychotropic Medications
12(1)
Social Work Role Categories
13(7)
Physician's Assistant
13(1)
Consultant
14(1)
Counselor
15(1)
Monitor
16(1)
Advocate
17(1)
Educator
18(1)
Researcher
19(1)
Social Worker Roles and Professional Values
20(1)
Current Medication-Related Activities of Social Workers
21(3)
Summary
24(2)
Topics for Discussion and Learning Activities
26(1)
2 Defining Effective Collaboration
27(20)
Principles of a Partnership Model of Practice
28(6)
Appreciate Participants' Strengths and Limits
28(1)
Embrace a Client-Centered Practice
29(2)
Reconceptualize the Client-Clinician Relationship
31(1)
Conceptualize the Role of the Social Worker as a Resource
32(1)
Appreciate the Family Member's Perspective
33(1)
Maintaining a Balanced Perspective
34(6)
Rights of Individual, Family, and Society
34(1)
Costs Versus Benefits of Medications
35(2)
Expanded Roles with Regard to Related Professions
37(3)
Integrating Psychosocial Interventions and Psychopharmacology
40(5)
Competing Ideologies
40(1)
Managing Parallel Treatment
41(4)
Summary
45(1)
Topics for Discussion and Learning Activities
45(2)
PART II A PRIMER ON PSYCHOPHARMACOLOGY 47(140)
3 Basic Principles of Neurotransmission, Pharmacokinetics, and Pharmacodynamics
49(33)
The Central Nervous System
50(5)
The Brain and Nervous System
51(4)
Properties of Nerve Cells
55(5)
Neuron Structure
55(2)
Neuron Function
57(3)
Neurotransmitters
60(3)
Acetylcholine
61(1)
Norepinephrine
61(1)
Dopamine
61(1)
Serotonin
61(1)
Gamma Aminobutyric Acid (GABA)
62(1)
Glutamate (Glutamic Acid)
62(1)
How a Drug Moves Through the Body
63(3)
Absorption
63(1)
Distribution
64(1)
Metabolism
65(1)
Excretion
65(1)
The Effects of a Drug on the Body
66(3)
The Placebo Effect
68(1)
Five Classes of Psychotropic Medication
69(7)
Antipsychotic Medications
69(2)
Antidepressant Medications
71(1)
Mood-Stabilizing Drugs
72(1)
Anti-Anxiety Medications
73(2)
Psychostimulants
75(1)
Adverse Effects of Psychotropic Medication
76(4)
Adverse Physical Effects: Definitions
76(2)
Adverse Physical Effects: Factors in Their Production
78(1)
Adverse Psychological Effects
79(1)
Adverse Social Effects
79(1)
Summary
80(1)
Topics for Discussion and Learning Activities
80(2)
4 Specific Medications for Specific Disorders
82(77)
Antipsychotic Medications
83(1)
Symptoms of Psychotic Disorders
83(4)
Specific Medications
87(11)
Origins
87(1)
Current Medications
88(3)
Conventional Antipsychotic Medications
91(2)
Adjunctive and Side-Effect Medications
93(1)
Newer Antipsychotic Medication
94(4)
Other Uses for Antipsychotic Medications
98(1)
Case Examples
98(2)
Antidepressant Medications
100(1)
Symptoms of Mood Disorders
101(1)
Specific Medications
102(12)
Origins
102(1)
Current Medications
103(1)
Antidepressant Medications and Relapse Prevention
104(1)
MAO Inhibitors
105(2)
Cyclic Antidepressants
107(3)
Selective Serotonin Reuptake Inhibitors
110(1)
Atypical Antidepressants
111(2)
Recent Advances in the Drug Treatment of Depression
113(1)
Special Concerns with Children and Adolescents
114(1)
Case Examples
114(2)
Mood-Stabilizing Medications
116(1)
Symptoms of Mania
117(2)
Specific Medications
119(11)
Origins
119(1)
Current Medications: Lithium
120(3)
Lithium for Relapse Prevention
123(1)
Anticonvulsant Medications
124(4)
Anticonvulsants for Relapse Prevention
128(1)
Antipsychotic Medications Used with Bipolar Disorder
129(1)
Antidepressant Medications Used with Bipolar Disorder
129(1)
Case Examples
130(3)
Anti-Anxiety Medications
133(1)
Symptoms of Anxiety Disorders
133(3)
Specific Medications
136(1)
Origins
136(1)
Current Medications
137(6)
The Benzodiazepines
137(3)
Buspirone
140(1)
Antidepressants Used with Anxiety Disorders
141(2)
Special Concerns with Children and Adolescents
143(1)
Protocols for Medication Use with the Anxiety Disorders
144(1)
Case Examples
144(2)
The Psychostimulants
146(1)
Attention-Deficit/Hyperactivity Disorder
146(1)
Ethical Issues in the Drug Treatment of Children
147(2)
Specific Medications
149(5)
Origins
149(1)
Current Medications
149(3)
Other Drugs Used to Treat ADHD
152(2)
Case Examples
154(3)
Summary
157(1)
Topics for Discussion and Learning Activities
157(2)
5 Intervention Concerns with Special Populations
159(28)
Sex Differences
160(3)
General Considerations
160(1)
Neurotransmitters
161(1)
Absorption
161(1)
Distribution
161(1)
Metabolism
162(1)
Classes of Medication
162(1)
Pregnancy
163(2)
Classes of Medication
164(1)
Sexual Adverse Effects of Medication
165(1)
Older Adults
166(5)
General Considerations
166(2)
Classes of Medication
168(3)
Medication Adherence
171(1)
Children and Adolescents
171(5)
General Considerations
171(2)
Classes of Medication
173(3)
Racial and Ethnic Differences
176(5)
African Americans
178(1)
People of Hispanic Culture
179(1)
Asian Americans
180(1)
People with a Dual Diagnosis of Mental Illness and Substance Abuse
181(4)
Mental Illness and Alcohol Abuse
184(1)
Summary
185(1)
Topics for Discussion and Learning Activities
185(2)
PART III KNOWLEDGE AND SKILLS FOR PSYCHOSOCIAL INTERVENTIONS 187(68)
6 Medication Education for Clients and Families
189(18)
Rationale for Medication Education
189(5)
Issues in Implementing and Evaluating Medication Education
194(6)
Content of Medication Education Programs
200(5)
Summary
205(1)
Topics for Discussion and Learning Activities
205(2)
7 Medication Adherence and Refusal
207(21)
Models for Understanding Adherence
210(1)
Characteristics of the Client
210(2)
Aspects of Treatment
212(3)
Aspects of the Social Environment
215(2)
Aspects of the Illness or Symptoms
217(1)
Legal and Ethical Issues in Adherence and Refusal
218(5)
Interventions to Assist in Medication Adherence
223(3)
Summary
226(1)
Suggestions for Class Activities and Assignments
227(1)
8 Medication Monitoring and Management
228(27)
Client Self-Monitoring of Medication
231(3)
Using Existing Measures to Guide Monitoring
234(3)
Concrete Steps for Coping with Adverse Effects
237(3)
Decision Making and Problem Solving in Medication Management
240(5)
Negotiating Medication Issues with Health Care Providers
245(4)
Advocacy in Medication Management
249(3)
Summary
252(1)
Topics for Discussion and Learning Activities
253(2)
PART IV FUTURE DIRECTIONS 255(19)
9 Future Directions in Psychopharmacology and Implications for Social Workers
257(17)
New Pharmaceutical Treatments
258(3)
The Emergence of Herbal and Vitamin Treatments
261(3)
Herbs
261(2)
Vitamins
263(1)
Expanding Prescription-Writing Privileges
264(4)
Increased Public Scrutiny of Psychotropic Medications
268(4)
Final Words
272(1)
Topics for Discussion and Learning Activities
273(1)
Glossary 274(17)
References 291(31)
Name Index 322(5)
Subject Index 327(6)
Alphabetical Listing of Currently Available Prescription Medications Described in This Book 333


Please wait while the item is added to your cart...